Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech

Psychopharmacology

Volumn 208, Issue 2, 2010, Pages 169-177

  Marrone, Gina F ^a,b,d   Pardo, Jennifer S ^d   Krauss, Robert M ^c   Hart, Carl L ^a,b,c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c NONE   (United States)

^d Program on US Russia Relations at Columbia s Harriman Institute   (United States)

Author keywords

Amphetamines; Ecstasy; Humans; Methamphetamine; Performance; Speech

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; METHAMPHETAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE; CENTRAL STIMULANT AGENT;

ADULT; ALERTNESS; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXPERIMENTAL DESIGN; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL CONCENTRATION; MENTAL FUNCTION; MENTAL PERFORMANCE; MOOD; NORMAL HUMAN; PERCEPTION; PRIORITY JOURNAL; RATING SCALE; RECREATION; SELF CONCEPT; SPEECH ARTICULATION; SPEECH RATE; AFFECT; AROUSAL; ATTENTION; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; SPEECH; SPEECH INTELLIGIBILITY;

3,4-METHYLENEDIOXYAMPHETAMINE; ADULT; AFFECT; AROUSAL; ATTENTION; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHAMPHETAMINE; SELF CONCEPT; SPEECH; SPEECH INTELLIGIBILITY; YOUNG ADULT;

EID: 77449117868     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1715-0     Document Type: Article

References (51)

1. BDM Carter CS Carter 2005 Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers Schizophr Res 77 43 58 10.1016/j.schres.2004.12.019 16005384
2. J Cami M Farre M Mas PN Roset S Poudevida A Mas L San R de la Torre 2000 Human pharmacology of 3, 4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects J Clin Psychopharmacol 20 455 466 10.1097/00004714-200008000-00010 1:CAS:528:DC%2BD3cXlsFymtLo%3D 10917407
3. AK Cho WP Melega R Kuczenski DS Segal 2001 Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse Synapse 39 161 166 10.1002/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E 1:CAS:528:DC%2BD3MXpsFah 11180503
4. J Cohen B MacWhinney M Flatt J Provost 1993 PsyScope: an interactive graphical system for designing and controlling experiments in the psychology laboratory using Macintosh computers Behav Res Meth Instr Comp 25 257 271
5. SD Comer M Haney RW Foltin MW Fischman 1996 Amphetamine self-administration by humans: modulation by contingencies associated with task performance Psychopharmacology (Berl) 127 39 46 10.1007/BF02805973 1:CAS:528:DyaK28Xlslanurs%3D
6. SD Comer CL Hart AS Ward M Haney RW Foltin MW Fischman 2001 Effects of repeated oral methamphetamine administration in humans Psychopharmacology 155 397 404 10.1007/s002130100727 1:CAS:528:DC%2BD3MXkvFShurc%3D 11441429
7. E Gouzoulis-Mayfrank L Hermle 1998 Are the "entactogens" a distinct psychoactive substance class? The contribution of human experimental studies to the classification of MDMA and other chemically related methylenedioxyamphetamine derivatives Heffter Rev Psych Res 1 46 51
8. G Greer R Tolbert 1986 Subjective reports of the effects of MDMA in a clinical setting J Psychoact Drugs 18 319 327 1:STN:280:DyaL2s7ktVGgtg%3D%3D
9. G Greer R Tolbert 1998 A method of conducting therapeutic sessions with MDMA J Psychoact Drugs 30 371 379 1:STN:280:DyaK1M7it1agsw%3D%3D
10. RR Griffiths M Stitzer K Corker G Bigelow I Liebson 1977 Drug-produced changes in human social behavior: facilitation by d-amphetamine Pharmacol Biochem Behav 7 365 372 10.1016/0091-3057(77)90233-7 1:CAS:528: DyaE1cXmvFaluw%3D%3D 928495
11. F Grosjean H Lane 1976 How the listener integrates the components of speaking rate J Exp Psychol Hum Percept Perform 4 538 543
12. FH Guenther 2006 Cortical interactions underlying the production of speech sounds J Commun Disord 39 350 365 10.1016/j.jcomdis.2006.06.013 16887139
13. PN Halkitis BN Fischgrund JT Parsons 2005 Explanations for methamphetamine use among gay and bisexual men in New York City Subst Use Misuse 40 1331 1345 10.1081/JA-200066900 16048820
14. CL Hart AS Ward M Haney RW Foltin MW Fischman 2001 Methamphetamine self-administration by humans Psychopharmacology 157 75 81 10.1007/s002130100738 1:CAS:528:DC%2BD3MXnsVelsLc%3D 11512046
15. CL Hart M Haney RW Foltin MW Fischman 2002 Effects of the NMDA antagonist memantine on human methamphetamine discrimination Psychopharmacology 164 376 384 10.1007/s00213-002-1225-9 1:CAS:528:DC%2BD38XptFehsr4%3D 12457267
16. CL Hart AS Ward M Haney J Nasser RW Foltin 2003 Methamphetamine attenuates disruptions in performance and mood during simulated night shift work Psychopharmacology 169 42 51 10.1007/s00213-003-1464-4 1:CAS:528: DC%2BD3sXmsFaru7g%3D 12734635
17. CL Hart EW Gunderson A Perez MG Kirkpatrick A Thurmond SD Comer RW Foltin 2008 Acute physiological and behavioral effects of intranasal methamphetamine in humans Neuropsychopharmacology 33 1847 1855 10.1038/sj.npp.1301578 1:CAS:528:DC%2BD1cXntFShs74%3D 17851535
18. SJ Heishman ML Stitzer 1989 Effect of d-amphetamine secobarbital and marijuana on choice behavior: social versus nonsocial options Psychopharmacology (Berl) 99 156 162 10.1007/BF00442801 1:CAS:528:DyaL1MXlvVOgtbc%3D
19. ST Higgins ML Stitzer 1988 Time allocation in a concurrent schedule of social interaction and monetary reinforcement: effects of d-amphetamine Pharmacol Biochem Behav 31 227 231 10.1016/0091-3057(88)90338-3 1:CAS:528:DyaL1MXltFagsQ%3D%3D 3252255
20. ST Higgins ML Stitzer 1989 Monologue speech: effects of d-amphetamine secobarbital and diazepam Pharmacol Biochem Behav 34 609 618 10.1016/0091-3057(89)90567-4 1:CAS:528:DyaK3cXkvVKqug%3D%3D 2623018
21. H Hollien G DeJong CA Martin 1998 Production of intoxication states by actors: Perception by lay listeners J Forensic Sci 43 1153 1162 1:STN:280:DyaK1M%2Fmt1yhsA%3D%3D 9846392
22. J Jaffe CC Dahlberg J Luria J Chorosh 1973 Effects of LSD-25 and dextroamphetamine on speech rhythms in psychotherapy dialogues Biol Psychiatry 6 93 96 1:STN:280:DyaE3s7psFerug%3D%3D 4710779
23. CE Johanson M Kilbey K Gatchalian M Tancer 2006 Discriminative stimulus effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo Drug Alcohol Depend 81 27 36 10.1016/j.drugalcdep.2005.05.003 1:CAS:528: DC%2BD2MXht1Onur7E 15975736
24. BA Johnson JD Roache N Ait-Daoud C Wallace LT Wells Y Wang 2005 Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition Psychopharmacology (Berl) 178 296 302 10.1007/s00213-004-1998-0 1:CAS:528:DC%2BD2MXhsVKru74%3D
25. HE Jones BE Garrett RR Griffiths 2001 Reinforcing effects of oral cocaine: contextual determinants Psychopharmacology (Berl) 154 143 152 10.1007/s002130000626 1:CAS:528:DC%2BD3MXitlSlsrw%3D
26. MG Kirkpatrick J Metcalfe MJ Greene CL Hart 2008 Effects of intranasal methamphetamine on metacognition of agency Psychopharmacology 197 137 144 10.1007/s00213-007-1018-2 1:CAS:528:DC%2BD1cXjsVCqsbs%3D 18043908
27. BC Kelly JT Parsons BE Wells 2006 Prevalence and predictors of club drug use among club-going young adults in New York City J Urban Health 83 884 895 10.1007/s11524-006-9057-2 16937088
28. F Klingholz R Penning E Liebhart 1988 Recognition of low-level alcohol intoxication from speech signal J Acoust Soc Am 84 929 935 10.1121/1.396661 1:STN:280:DyaL1M%2FjsFWmtA%3D%3D 3183210
29. KP Kuypers JG Ramaekers 2005 Transient memory impairment after acute dose of 75 mg 34-methylene-dioxymethamphetamine J Psychopharmacol 19 633 639 10.1177/0269881105056670 1:CAS:528:DC%2BD2MXht1Kru77E 16272186
30. ME Liechti A Gamma FX Vollenweider 2001 Gender differences in the subjective effects of MDMA Psychopharmacology (Berl) 154 161 168 10.1007/s002130000648 1:CAS:528:DC%2BD3MXitlSlsro%3D
31. BK Logan 1996 Methamphetamine and driving impairment J Forensic Sci 41 457 464 1:STN:280:DyaK283js1agsw%3D%3D 8656187
32. GA Maguire LA Gottschalk GD Riley DL Franklin RJ Bechtel J Ashurst 1999 Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity Compr Psychiatry 40 308 314 10.1016/S0010-440X(99)90132-3 1:STN:280:DyaK1MzlsFWntw%3D%3D 10428191
33. WR Martin JW Sloan JD Sapira DR Jasinski 1971 Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man Clin Pharmacol Ther 12 245 258 1:CAS:528:DyaE3MXhtl2gtLw%3D 5554941
34. SM McGee DN McGee MB McGee 2004 Spontaneous intracerebral hemorrhage related to methamphetamine abuse: autopsy findings and clinical correlation Am J Forensic Med Pathol 25 334 337 10.1097/01.paf.0000137206.16785.2f 15577524
35. M Natale CC Dahlberg J Jaffe 1979 The effect of psychotomimetics on therapist-patient matching of speech "rhythms" J Commun Disord 12 45 52 10.1016/0021-9924(79)90020-0 1:STN:280:DyaE1M7jtVOrtA%3D%3D 370160
36. DE Patterson SE Braverman PV Belandres 1997 Speech dysfunction due to trazodone-fluoxetine combination in traumatic brain injury Brain Injury 11 287 291 10.1080/026990597123593 1:STN:280:DyaK2s3nvFyhuw%3D%3D 9134203
37. DB Pisoni CS Martin 1989 Effects of alcohol on the acousticphonetic properties of speech: perceptual and acoustic analyses Alcohol Clin Exp Res 13 577 587 10.1111/j.1530-0277.1989.tb00381.x 1:STN:280:DyaK3c%2FisVahsQ%3D%3D 2679214
38. Pisoni DB Yuchtman M Hathaway N (1986) Effects of alcohol on the acousticphonetic properties of speech In: Alcohol accidents and injuries. Society of Automotive Engineers, Pittsburgh, PA, special paper P-173, 131-150
39. J Rodgers T Buchanan C Pearson AC Parrott J Ling TM Hefferman AB Scholey 2006 Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study J Psychopharmacol 20 437 446 10.1177/0269881105058777 16174668
40. RB Rothman MH Baumann CM Dersch DV Romero KC Rice FI Carroll JS Partilla 2001 Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 32 41 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3 1:CAS:528:DC%2BD3cXovFahsLg%3D 11071707
41. SAMHSA (2008) Tips for teens: the truth about club drugs. http://ncadisamhsagov/govpubs/phd852/
42. SJ Semple TL Patterson I Grant 2003 Binge use of methamphetamine among HIV-positive men who have sex with men: pilot data and HIV prevention implications AIDS Educ Prev 15 133 147 10.1521/aeap.15.3.133.23835
43. RJ Sevak WW Stoops LR Hays CR Rush 2009 Discriminative stimulus and subject-rated effects of methamphetamine d-amphetamine methylphenidate and triazolam in methamphetamine-trained humans J Pharmacol Exp Ther 328 1007 1010 10.1124/jpet.108.147124 1:CAS:528:DC%2BD1MXislalsbc%3D 19104030
44. BY Silber RJ Croft K Papafotiou C Stough 2006 The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance Psychopharmacology 187 154 169 10.1007/s00213-006-0410-7 1:CAS:528: DC%2BD28Xms1Gqur8%3D 16761129
45. K Silverman KC Kirby RR Griffiths 1994 Modulation of drug reinforcement by behavioral requirements following drug ingestion Psychopharmacology (Berl) 114 243 247 10.1007/BF02244844 1:STN:280:DyaK2M7ktVygtQ%3D%3D
46. ML Stitzer RR Griffiths I Liebson 1978 Effects of d-amphetamine on speaking in isolated humans Pharmacol Biochem Behav 9 57 63 10.1016/0091- 3057(78)90013-8 1:CAS:528:DyaE1MXmtFM%3D 704653
47. WW Stoops JA Lile MT Fillmore PE Glaser CR Rush 2005 Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration Psychopharmacology (Berl) 177 349 355 10.1007/s00213-004-1946-z 1:CAS:528:DC%2BD2cXhtVyltL3L
48. WW Stoops JA Lile MT Fillmore PE Glaser CR Rush 2005 Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration Psychopharmacology (Berl) 182 186 193 10.1007/s00213-005-0044-1 1:CAS:528:DC%2BD2MXhtVOitb7N
49. M Tancer CE Johanson 2003 Reinforcing subjective and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP Drug Alcohol Depend 72 33 44 10.1016/S0376-8716(03)00172-8 1:CAS:528:DC%2BD3sXotVylsLs%3D 14563541
50. M Tancer CE Johanson 2007 The effects of fluoxetine on the subjective and physiological effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans Psychopharmacology 189 565 573 10.1007/s00213-006-0576-z 1:CAS:528: DC%2BD28Xht1entL7P 17047932
51. FX Vollenweider A Gamma M Liechti T Huber 1998 Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers Neuropsychopharmacology 19 241 251 1:CAS:528:DyaK1cXlslWktb0%3D 9718588